Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 236813

1.

Biology of Nodal Spread in Colon Cancer: Insights from Molecular and Genetic Studies.

Kandagatla P, Maguire LH, Hardiman KM.

Eur Surg Res. 2018 Dec 11;59(5-6):361-370. doi: 10.1159/000494832. [Epub ahead of print]

PMID:
30537705
2.

A novel MUC1 aptamer-modified PLGA-epirubicin-PβAE-antimir-21 nanocomplex platform for targeted co-delivery of anticancer agents in vitro and in vivo.

Bahreyni A, Alibolandi M, Ramezani M, Sarafan Sadeghi A, Abnous K, Taghdisi SM.

Colloids Surf B Biointerfaces. 2018 Dec 4;175:231-238. doi: 10.1016/j.colsurfb.2018.12.006. [Epub ahead of print]

PMID:
30537619
3.

The risk of cancer attributable to diagnostic medical radiation: Estimation for France in 2015.

Marant-Micallef C, Shield KD, Vignat J, Cléro E, Kesminiene A, Hill C, Rogel A, Vacquier B, Bray F, Laurier D, Soerjomataram I.

Int J Cancer. 2018 Dec 8. doi: 10.1002/ijc.32048. [Epub ahead of print]

PMID:
30537057
4.

Complications after discharge and delays in adjuvant chemotherapy following colonic resection: a cohort study of linked primary and secondary care data.

Arhi CS, Burns EM, Bouras G, Aylin P, Ziprin P, Darzi A.

Colorectal Dis. 2018 Dec 10. doi: 10.1111/codi.14525. [Epub ahead of print]

PMID:
30537049
5.

Vaccines for colorectal cancer: an update.

Sarvizadeh M, Ghasemi F, Tavakoli F, Sadat Khatami S, Razi E, Sharifi H, Biouki NM, Taghizadeh M.

J Cell Biochem. 2018 Dec 9. doi: 10.1002/jcb.28179. [Epub ahead of print]

PMID:
30536960
6.
7.

Exosomes as a novel cell-free therapeutic approach in gastrointestinal diseases.

Baghaei K, Tokhanbigli S, Asadzadeh H, Nmaki S, Reza Zali M, Hashemi SM.

J Cell Physiol. 2018 Dec 7. doi: 10.1002/jcp.27934. [Epub ahead of print] Review.

PMID:
30536895
8.

Gene-environment interactions and colorectal cancer risk: an umbrella review of systematic reviews and meta-analyses of observational studies.

Yang T, Li X, Montazeri Z, Little J, Farrington SM, Ioannidis JP, Dunlop MG, Campbell H, Timofeeva M, Theodoratou E.

Int J Cancer. 2018 Dec 11. doi: 10.1002/ijc.32057. [Epub ahead of print] Review.

PMID:
30536881
9.

Incidence, severity, longitudinal trends and predictors of acute and chronic oxaliplatin-induced peripheral neuropathy in Taiwanese patients with colorectal cancer.

Hsu SY, Huang WS, Lee SH, Chu TP, Lin YC, Lu CH, Beaton RD, Jane SW.

Eur J Cancer Care (Engl). 2018 Dec 10:e12976. doi: 10.1111/ecc.12976. [Epub ahead of print]

PMID:
30536809
10.

Impact of Oxidative Metabolism on the Cytotoxic and Genotoxic Potential of Genistein in Human Colon Cancer Cells.

Schroeter A, Aichinger G, Stornig K, Marko D.

Mol Nutr Food Res. 2018 Nov 22:e1800635. doi: 10.1002/mnfr.201800635. [Epub ahead of print]

PMID:
30536621
11.

Global trends in colorectal cancer mortality: projections to the year 2035.

Araghi M, Soerjomataram I, Jenkins M, Brierley J, Morris E, Bray F, Arnold M.

Int J Cancer. 2018 Dec 10. doi: 10.1002/ijc.32055. [Epub ahead of print]

PMID:
30536395
12.
13.

Risk of cancer after assisted reproduction: a review of the available evidences and guidance to fertility counselors.

Del Pup L, Peccatori FA, Levi-Setti PE, Codacci-Pisanelli G, Patrizio P.

Eur Rev Med Pharmacol Sci. 2018 Nov;22(22):8042-8059. doi: 10.26355/eurrev_201811_16434.

PMID:
30536354
14.

Oxygen-ozone therapy as support and palliative therapy in 50 cancer patients with fatigue - A short report.

Tirelli U, Cirrito C, Pavanello M, Del Pup L, Lleshi A, Berretta M.

Eur Rev Med Pharmacol Sci. 2018 Nov;22(22):8030-8033. doi: 10.26355/eurrev_201811_16432.

PMID:
30536352
15.

Contribution of the OC Sensor® immunoassay in comparison to the Hemoccult II® guaiac-test in organized colorectal cancer screening.

Vitellius C, Laly M, Banaszuk AS, Deherce I, Cornet N, Bertrais S, Saulnier P, Caroli-Bosc FX.

Eur J Epidemiol. 2018 Dec 8. doi: 10.1007/s10654-018-0471-z. [Epub ahead of print]

PMID:
30536183
16.

Role of Inflammasomes in the Development of Gastrointestinal Diseases.

Kanak MA, Shindo Y, SaiKumar P, Naziruddin B.

Exp Suppl. 2018;108:235-268. doi: 10.1007/978-3-319-89390-7_10.

PMID:
30536174
17.

Does enhanced recovery improve the survival rates of patients 3 years after undergoing surgery to remove a tumor in the colon?

Viannay P, Hamy A, Jaouen R, Caroli-Bosc FX, Luel C, Vasseur S, Levaillant M, Hamel JF, Venara A.

Int J Colorectal Dis. 2018 Dec 7. doi: 10.1007/s00384-018-3205-5. [Epub ahead of print]

PMID:
30536115
18.

Targeting neratinib-induced diarrhea with budesonide and colesevelam in a rat model.

Secombe KR, Ball IA, Shirren J, Wignall AD, Finnie J, Keefe D, Avogadri-Connors F, Olek E, Martin D, Moran S, Bowen JM.

Cancer Chemother Pharmacol. 2018 Dec 10. doi: 10.1007/s00280-018-3756-8. [Epub ahead of print]

PMID:
30535958
19.

Receptor Tyrosine Kinase EphB3: a Prognostic Indicator in Colorectal Carcinoma.

Xuan Z, Huang J, Gao L, Wang Y, Wang J, Sun Y.

Pathol Oncol Res. 2018 Dec 7. doi: 10.1007/s12253-018-0562-x. [Epub ahead of print]

PMID:
30535864
20.

Identification of tissue-specific tumor biomarker using different optimization algorithms.

Bhowmick SS, Bhattacharjee D, Rato L.

Genes Genomics. 2018 Dec 8. doi: 10.1007/s13258-018-0773-2. [Epub ahead of print]

PMID:
30535858

Supplemental Content

Loading ...
Support Center